Induced pluripotency with endogenous and inducible genes

Area of Science:

• Stem cell biology
• Molecular biology
• Regenerative medicine

Background:

• Nuclear reprogramming of somatic cells can generate induced pluripotent stem cells (iPSCs).
• Current methods often use four genes (Oct4, Sox2, Klf4, c-Myc) delivered via retroviruses, posing safety concerns for clinical use due to oncogene integration and potential for cancer.
• Identifying safer, more efficient reprogramming strategies is crucial for therapeutic applications.

Purpose of the Study:

• To develop a safer cell reprogramming protocol by utilizing endogenous gene expression.
• To investigate if neural stem cells (NSCs), which naturally express certain reprogramming factors, are predisposed to reprogramming.
• To reduce the number of exogenous genes required for reprogramming.

Main Methods:

• Utilized mouse neural stem (NS) cells, which endogenously express SoxB1 family proteins.
• Introduced three reprogramming transcription factors: Oct4, Klf4, and c-Myc (or MYCER(TAM)).
• Assessed the reprogramming efficiency and pluripotency of the resulting cells through in vitro and in vivo differentiation assays.

Main Results:

• Successfully reprogrammed mouse neural stem cells using a combination of Oct4, Klf4, and c-Myc, leveraging endogenous SoxB1.
• The reprogrammed cells exhibited pluripotency, differentiating into derivatives of all three germ layers both in vitro and in vivo.
• These reprogrammed cells contributed to the development of chimeric mice, demonstrating their developmental potential.

Conclusions:

• A combinatorial reprogramming approach using inducible transgenes and exploiting endogenously expressed genes offers a safer alternative to traditional methods.
• Neural stem cells are amenable to reprogramming with a reduced set of factors due to their inherent gene expression profile.
• This strategy holds promise for advancing cell replacement therapies by improving the safety and efficiency of reprogramming protocols.